Why Is ABCELLERA BIOLOGICS (ABCL) Stock Up Today?

ABCL stock surged 13.15 percent to $12.01 on Wednesday driven by a strong intraday rally and positive sentiment following recent insider buying and a new public offering. The stock opened with a 3.6 percent gap up and climbed further during the session reaching a high of $12.15. The move reflects improved market confidence and increased trading volume which is currently 0.4 times the 3-month daily average.

What Happened

AbCellera Biologics shares rose sharply as the stock opened at $10.99 and continued to climb throughout the session. The stock reached an intraday high of $12.15 at 10:35 AM ET before settling at $12.01. This represents a significant move within a single trading session and brings the stock to its 52-week high. The rally follows a recent $200 million public offering of common shares at $9.75 per share which was reported as oversubscribed. Recent insider transactions also indicate confidence in the company with several directors and the CFO purchasing shares in the past month.

What The Data Shows

The stock has shown a positive price trend over the last 8 sessions rising from $10.51 to $10.61. The recent rally has pushed the stock to a 52-week high with 21 fresh 52-week highs recorded on August 25. The company's fundamentals show it is unprofitable with an EPS TTM of -0.55 and a net margin of -248.8 percent. However revenue has grown by 101.3 percent TTM. The stock has a market cap of $3.7 billion and a beta of 1.19. Recent insider transactions include four buys totaling $1.5 million with no sells reported in the last 90 days.

What To Watch

Investors should monitor the company's upcoming earnings if any are scheduled. In the absence of a specific date the broader coverage and market reaction to the recent offering and insider buying will be key to watch.